Scotia Vision Founder Michael O’Rourke presents at the 2011 annual “Controlled Release Society” meeting on “Market Development Strategies For Ocular Drug Delivery Systems”

“Ocular drug delivery is one of the most challenging endeavors due to the unique anatomy and physiology of the eye. This focus group will provide a forum for scientists from both industry and academia to share experiences, communicate lessons learned, and exchange information regarding novel biomaterials, formulations, delivery technologies, ocular pharmacokinetics and pharmacodynamics, and regulatory issues related to the development of ocular drug delivery systems. The mission of the focus group is to facilitate the understanding of key factors that influence and key issues that hinder effective drug delivery to the target tissues of the eye. The Ocular Drug Delivery Focus Group was established in April 2011.”

For more details visit:

For details contact Michael O’Rourke